Incyte at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Incyte exhibits at Booth 228, 1113 at ASH 2026 in New Orleans. Incyte supports symposia on myelofibrosis and non-Hodgkin lymphoma aimed at practical treatment choices. The lymphoma program answers the questions community oncologists raise about newer therapies, while the myelofibrosis program works through patient cases to show where care is heading.
| Organization | ASH 2026 Attendance |
|---|---|
Incyte Wilmington, DE | |
Biopharmaceutical company discovering, developing and marketing its own medicines in oncology and in inflammation and autoimmunity. | Booth Exhibiting at Booth 228, 1113 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 3:00pm–6:00pm A Case-Based Exploration of Current and Future Directions in Myelofibrosis – Where We Are, Where We’re Going Real patient cases showing how experts treat myelofibrosis today, paired with reviews of current data and ongoing research on emerging therapies. Symposium Fri Dec 11 7:00pm–10:00pm Addressing Community Oncologists’ Questions About Novel Therapies in Non-Hodgkin Lymphoma – What Clinicians Want To Know: A CME-Accredited Friday Satellite Symposium Preceding the 68th ASH Annual Meeting Answers to community oncologists' most pressing questions about new drugs for non-Hodgkin lymphoma, drawn from a survey and reviewed against current research. |
Instantly find 20 buyers from Incyte
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction